Skip to Main Content
Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We expect to hang with one of the short people, promenade with the official mascot, and fortify the Pharmalot campus against the usual assortment of noisy little ghouls and goblins who are scheduled to arrive. It is that time of the year, after all. Before we forget, here is a number to help you get in the mood. And what, exactly, will you be doing? This remains a lovely time to take a spin through the countryside — perhaps the Great Pumpkin will be waiting. You can decide how to vote on Election Day, or convince someone to get vaccinated. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

House Speaker Nancy Pelosi is working to gather support for a last-ditch proposal to lower prescription drug costs after the White House shunned the issue, STAT writes. The new policy would allow Medicare to negotiate drug prices for medications administered by doctors and at pharmacies, after their exclusivity periods granted by U.S. regulators expire. The tentative deal would also penalize drug makers for raising prices faster than inflation in both the employer-sponsored insurance market and Medicare. Seniors would have their out-of-pocket drug costs capped each year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment